What 21 CFR Part 203 - Prescription Drug Marketing (Samples and Wholesale Distribution) requires
21 CFR Part 203 implements the Prescription Drug Marketing Act and governs the sale, purchase, distribution and sampling of prescription drugs…
This is a preview. The full record adds the complete summary, 8 workflow steps, 9 schema fields and 8 primary citations. Start a free trial or see pricing.
Pillar: Pharmaceuticals & Life Sciences · Authority: U.S. Food and Drug Administration (FDA) · Version: 1.0.0 · Last updated:
Primary source: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-203
SHA-256 integrity: cd1b970fb0f4ab7057d890279486f2b93163adfe9afc8e1d943c2199f84b3cb4
Primary Citations — 8 traced to source
- 21 CFR Part 203, §203.20 - sales restrictions on prescription drugs purchased by health care entities or donated to charity
- 21 CFR Part 203, §203.30 - drug sample distribution by mail or common carrier (written request, license verification, signed receipt)
+ 6 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/us-fda-21-cfr-203-prescription-drug-marketing.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/us-fda-21-cfr-203-prescription-drug-marketing.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/us-fda-21-cfr-203-prescription-drug-marketing
- Back to registry: Browse all 10,102 compliance nodes